Sodium Valproate .... NTI? [Regulatives / Guidelines]

posted by hari emmadi – India, 2016-09-21 12:19 (3212 d 13:54 ago) – Posting: # 16655
Views: 2,598

Dear All,

Greetings....

We are planning to conduct bioequivalence study of sodium valproate crushable tablets 100 mg for TGA submission. Sodium valproate is CNS category of drug. In view of this, we would like to know whether this drug falls under category of narrow therapeutic index (NTI) or not?

Complete thread:

UA Flag
Activity
 Admin contact
23,428 posts in 4,929 threads, 1,693 registered users;
54 visitors (0 registered, 54 guests [including 10 identified bots]).
Forum time: 02:14 CEST (Europe/Vienna)

If I’d observed all the rules,
I’d never have got anywhere.    Marilyn Monroe

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5